USFDA granted approval to Aurobindo Pharma for Flucytosine Capsules

Aurobindo Pharma received its final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg.

Flucytosine Capsules are used for the treatment of serious infections caused by susceptible strains of Candida and Cryptococcus. The Capsules are a generic version of Bausch Health’s Ancobon Capsules and the capsules will be launched in June 2020.

A total of 429 ANDA approvals has been granted to Aurobindo (401 Final approvals including 23 from Aurolife Pharma LLC and 28 tentative approvals) from USFDA.

  • Related Posts

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy